A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)

NCT04169906 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Placebo
DRUG: TS-142, 10 mg
DRUG: TS-142, 20 mg
DRUG: TS-142, 30 mg

Sponsor

Taisho Pharmaceutical Co., Ltd.